|
|
| Line 1: |
Line 1: |
| {{Navbox with collapsible groups
| | #REDIRECT [[Template:Oral hypoglycemics and insulin analogs]] |
| | name = Oral hypoglycemics and insulin analogs/ja
| |
| | title = 経口[[diabetes medication/ja|糖尿病治療薬]]、[[insulin/ja|インスリン]]製剤および[[insulin analog/ja|インスリンアナログ]]製剤、糖尿病に用いられるその他の薬剤（[[ATC codeA10/ja|A10]]）
| |
| | state = {{{state<includeonly>|expanded</includeonly>}}}
| |
| | listclass = hlist
| |
| | |
| | group1 = [[Insulin/ja|インスリン]]/[[insulin analog/ja|インスリンアナログ]]
| |
| | list1 = {{Navbox|child
| |
| | |
| | group1 = ''超速効型''
| |
| | list1=
| |
| * [[Insulin aspart/ja]]
| |
| * [[Insulin glulisine/ja]]
| |
| * [[Insulin lispro/ja]]
| |
|
| |
| | group2 = ''速効型''
| |
| | list2 =
| |
| * [[Regular insulin/ja]]<sup>#</sup>
| |
| | |
| | group3 = ''長時間作用型''
| |
| | list3 =
| |
| * [[Insulin detemir/ja]]<sup>#</sup>
| |
| * [[Insulin glargine/ja]]<sup>#</sup> ([[Insulin glargine/lixisenatide/ja|+リキセナチド]])
| |
| * [[NPH insulin/ja]]
| |
| * [[Lente insulin/ja]]<sup>‡</sup>
| |
| * [[Ultralente insulin/ja]]<sup>‡</sup>
| |
| | |
| | group4 = ''超長時間作業型''
| |
| | list4 =
| |
| * [[Insulin degludec/ja]]<sup>#</sup> ([[Insulin degludec/insulin aspart/ja|+インスリンアスパルト]], [[Insulin degludec/liraglutide/ja|+リラグルチド]])
| |
| * [[Insulin icodec/ja]]<sup>†</sup> ([[Insulin icodec/semaglutide/ja|+セマグルチド]])
| |
| | |
| | group5 = ''[[Inhalable insulin/ja|吸入可能]]''
| |
| | list5 =
| |
| * Exubera<sup>‡</sup>
| |
| * Afrezza
| |
| }}
| |
| {{PharmNavFootnote}}
| |
| | |
| | group2 = 非インスリン
| |
| | list2= {{navbox|child|
| |
| | group1 = [[Anti-diabetic medication#Sensitizers/ja|インスリン感作薬]]
| |
| | list1 = {{Navbox|child
| |
| | |
| | group1 = [[Biguanide/ja]]
| |
| | list1 =
| |
| * [[Buformin/ja]]<sup>‡</sup>
| |
| * [[Metformin/ja]]<sup>#</sup>
| |
| * [[Phenformin/ja]]<sup>‡</sup>
| |
| | |
| | group2 = [[Thiazolidinedione/ja|TZD]]/"グリタゾン" ([[PPAR agonist/ja|PPAR]])
| |
| | list2 =
| |
| * [[Ciglitazone/ja]]<sup>§</sup>
| |
| * [[Darglitazone/ja]]<sup>§</sup>
| |
| * [[Englitazone/ja]]<sup>§</sup>
| |
| * [[Lobeglitazone/ja]]
| |
| * [[Netoglitazone/ja]]<sup>§</sup>
| |
| * [[Pioglitazone/ja]]
| |
| * [[Rivoglitazone/ja]]<sup>†</sup>
| |
| * [[Rosiglitazone/ja]]
| |
| * [[Troglitazone/ja]]<sup>‡</sup>
| |
| | |
| | group3 = [[PPAR agonist/ja#Dual PPAR agonists|デュアルPPAR作動薬]]
| |
| | list3 =
| |
| * [[Aleglitazar/ja]]<sup>†</sup>
| |
| * [[Muraglitazar/ja]]<sup>§</sup>
| |
| * [[Saroglitazar/ja]]
| |
| * [[Tesaglitazar/ja]]<sup>§</sup>
| |
| | |
| | |
| | group4 = [[Amylin/ja]]アナログ と [[DACRA/ja|DACRA]]
| |
| | list4 =
| |
| * [[Cagrilintide/ja]]<sup>§</sup>
| |
| * [[Pramlintide/ja]]
| |
| }}
| |
| | |
| | group2 = [[Anti-diabetic medication/ja#Secretagogues|セクレタゴーグ]]
| |
| | list2 = {{Navbox|child
| |
| | |
| | group1 = [[ATP-sensitive potassium channel/ja|K<sup>+</sup><sub>ATP</sub>]]
| |
| | list1 = {{Navbox|child
| |
| | evenodd = swap
| |
| | |
| | group1 = [[Sulfonylurea/ja]]
| |
| | list1 =
| |
| * ''第一世代'': [[Acetohexamide/ja]]
| |
| * [[Carbutamide/ja]]
| |
| * [[Chlorpropamide/ja]]
| |
| * [[Glycyclamide/ja]]
| |
| * [[Metahexamide/ja]]
| |
| * [[Tolazamide/ja]]
| |
| * [[Tolbutamide/ja]]
| |
| | |
| * ''第二世代'': [[Glibenclamide/ja|グリベンクラミド（グリブリド）]]
| |
| * [[Glibornuride/ja]]
| |
| * [[Glicaramide/ja]]
| |
| * [[Gliclazide/ja]]<sup>#</sup>
| |
| * [[Glimepiride/ja]]
| |
| * [[Glipizide/ja]]
| |
| * [[Gliquidone/ja]]
| |
| * [[Glisoxepide/ja]]
| |
| * [[Glyclopyramide/ja]]
| |
| | |
| | group2 = [[Meglitinide/ja]]/"グリニド系"
| |
| | list2 =
| |
| * [[Mitiglinide/ja]]
| |
| * [[Nateglinide/ja]]
| |
| * [[Repaglinide/ja]]
| |
| | |
| }}
| |
| | |
| | group2 = [[Glucagon-like peptide-1 receptor agonist/ja|GLP-1受容体作動薬]]
| |
| | list2 =
| |
| * [[Albiglutide/ja]]<sup>‡</sup>
| |
| * [[Danuglipron/ja]]<sup>†</sup>
| |
| * [[Dulaglutide/ja]]
| |
| * [[Exenatide/ja]]
| |
| * [[Liraglutide/ja]]
| |
| * [[Lixisenatide/ja]]
| |
| * [[Orforglipron/ja]]<sup>§</sup>
| |
| * [[Semaglutide/ja]]
| |
| * [[Taspoglutide/ja]]<sup>†</sup>
| |
| {{navbox|child|
| |
| group1=[[GLP1 poly-agonist peptides/ja]]
| |
| |list1=
| |
| * [[Mazdutide/ja]] (GLP-1/[[Glucagon receptor/ja|GCGR]])
| |
| * [[Retatrutide/ja]]<sup>§</sup> (GLP-1/GIP/GCGR)
| |
| * [[Tirzepatide/ja]] (GLP-1/GIP)
| |
| }}
| |
| | group3 = [[Dipeptidyl peptidase-4 inhibitor/ja|DPP-4 阻害薬]]/"グリプチン"
| |
| | list3 =
| |
| * [[Alogliptin/ja]]
| |
| * [[Anagliptin/ja]]
| |
| * [[Evogliptin/ja]]
| |
| * [[Garvagliptin/ja]]
| |
| * [[Gemigliptin/ja]]
| |
| * [[Gosogliptin/ja]]
| |
| * [[Linagliptin/ja]]
| |
| * [[Melogliptin/ja]]
| |
| * [[Omarigliptin/ja]]
| |
| * [[Saxagliptin/ja]]
| |
| * [[Sitagliptin/ja]]
| |
| * [[Teneligliptin/ja]]
| |
| * [[Trelagliptin/ja]]
| |
| * [[Vildagliptin/ja]]
| |
| }}
| |
| |group3 = その他
| |
| |list3 = {{navbox|child
| |
| | group1 = [[Aldose reductase inhibitor/ja]]
| |
| | list1 =
| |
| * [[Epalrestat/ja]]
| |
| * [[Fidarestat/ja]]<sup>§</sup>
| |
| * [[Ranirestat/ja]]<sup>†</sup>
| |
| * [[Tolrestat/ja]]<sup>‡</sup>
| |
| * [[Zenarestat/ja]]<sup>§</sup>
| |
| | |
| | group2 = [[Alpha-glucosidase inhibitor/ja]]
| |
| | list2 =
| |
| * [[Acarbose/ja]]
| |
| * [[Miglitol/ja]]
| |
| * [[Voglibose/ja]]
| |
| | |
| | group4 = [[Gliflozin/ja|SGLT2 阻害薬]]/"グリフロジン"
| |
| | list4 =
| |
| * [[Canagliflozin/ja]]
| |
| * [[Dapagliflozin/ja]]
| |
| * [[Empagliflozin/ja]]<sup>#</sup>
| |
| * [[Ertugliflozin/ja]]
| |
| * [[Ipragliflozin/ja]]
| |
| * [[Luseogliflozin/ja]]
| |
| * [[Remogliflozin etabonate/ja|レモグリフロジン]]<sup>§</sup>
| |
| * [[Sergliflozin etabonate/ja|セルグリフロジン]]<sup>§</sup>
| |
| * [[Sotagliflozin/ja]]
| |
| * [[Tofogliflozin/ja]]<sup>†</sup>
| |
| * [[Velagliflozin/ja]]
| |
| | |
| | group5 = その他
| |
| | list5 =
| |
| * [[Benfluorex/ja]]<sup>‡</sup>
| |
| * [[Bromocriptine/ja]]
| |
| * [[Imeglimin/ja]]
| |
| }}
| |
| |group4 = [[Combination drug/ja|配合薬]]
| |
| |list4 = {{navbox|child
| |
| |list1 =
| |
| * [[Alogliptin/metformin/ja]]
| |
| * [[Canagliflozin/metformin/ja]]
| |
| * [[Cagrilintide/semaglutide/ja]]<sup>§</sup>
| |
| * [[Dapagliflozin/metformin/ja]]
| |
| * [[Dapagliflozin/saxagliptin/ja]]
| |
| * [[Dapagliflozin/saxagliptin/metformin/ja]]
| |
| * [[Empagliflozin/linagliptin/ja]]
| |
| * [[Empagliflozin/metformin/ja]]
| |
| * [[Gemigliptin/rosuvastatin/ja]]
| |
| * [[Glibenclamide/metformin/ja|グリベンクラミド(グリブリド)/メトホルミン]]
| |
| * [[Glimepiride/rosiglitazone/ja]]
| |
| * [[Linagliptin/metformin/ja]]
| |
| * [[Metformin/acarbose/ja]]
| |
| * [[Metformin/ertugliflozin/ja]]
| |
| * [[Metformin/evogliptin/ja]]
| |
| * [[Metformin/gemigliptin/ja]]
| |
| * [[Metformin/repaglinide/ja]]
| |
| * [[Metformin/sulfonylureas/ja]]
| |
| * [[Metformin/teneligliptin/ja]]
| |
| * [[Phenformin/sulfonylureas/ja]]
| |
| * [[Pioglitazone/alogliptin/ja]]
| |
| * [[Pioglitazone/glimepiride/ja]]
| |
| * [[Pioglitazone/metformin/ja]]
| |
| * [[Pioglitazone/sitagliptin/ja]]
| |
| * [[Rosiglitazone/metformin/ja]]
| |
| * [[Saxagliptin/metformin/ja]]
| |
| * [[Sitagliptin/dapagliflozin/ja]]
| |
| * [[Sitagliptin/ertugliflozin/ja]]
| |
| * [[Sitagliptin/metformin/ja]]
| |
| * [[Simvastatin/sitagliptin/ja|シタグリプチン/シンバスタチン]]
| |
| * [[Vildagliptin/metformin/ja]]
| |
| | |
| }}
| |
| }}
| |
| {{PharmNavFootnote}}
| |
| }}
| |
| <noinclude>
| |
| {{Collapsible option}}
| |
| [[Category:Drug templates by ATC]]
| |
| </noinclude>
| |